Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05556928

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers

Summary

The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.

Detailed description

All participants will be invited to participate in a patient reported geriatric assessment questionnaire as well as an objective physical function testing. This includes the Short Physical Performance Battery (SPPB) that evaluates lower extremity performance and muscle strength assessment via hand grip dynamometer. Participants will also complete a 12 item modified version of PRO-CTCAE. This will be administered by trained research staff at the time of study enrollment. Repeat CARE instruments (Follow-up GA questionnaire and Physical Function test) will be administered after the baseline visit to measure changes in patient reported outcomes at 3 months, 6 months, and one year. A one-time blood or saliva sample will be requested and obtained at baseline or a follow-up visit.

Conditions

Timeline

Start date
2020-07-21
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2022-09-27
Last updated
2025-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05556928. Inclusion in this directory is not an endorsement.

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry (NCT05556928) · Clinical Trials Directory